Genenta Science

ATC designs and manufactures high-precision tactical systems, including rifles, optics, and accessories.

Genenta plans to acquire privately held businesses in defense, aerospace, and security to enhance operations and governance.

Sòphia High Tech manufactures precision mechanical components for aerospace and defense systems.

Temferon is a gene-modified HSPC-based platform designed for controlled therapeutic gene expression in oncology.

Economic Security is reshaping the global investment landscape.

Fondazione Praexidia presented research on the transfer of control of Italian companies during its annual conference at the Camera dei Deputati.

For Press releases please visit https://ir.genenta.com/news-events/news-releases For Media inquiries please contact Tiziana Pollio tiziana.pollio@genenta.com

Barbara Regonini has experience in strategic finance, restructuring, internal controls, and corporate governance, including roles at Genenta, OAM, and PriceWaterhouseCoopers.

Dr. Francesco Galimi has over 30 years of experience in healthcare R&D, including roles at Adicet Bio and Amgen.

Gianfranco de Nigris has a background in finance and corporate development, with experience at Kairos Partners, NM Rothschild & Sons, Mediobanca, and Banca Generali.

Mr. Salvato previously led Fiocchi Munizioni S.p.A. and has over two decades of experience in defense industrial operations.

Saentra Forge identifies, acquires and actively develops scale-up companies operating in sectors protected by Golden Power frameworks — including defense, aerospace, cybersecurity, life sciences and critical infrastructure.

Sky TG24 featured Sòphia High Tech for its ultra-high-precision aerospace components, based in Somma Vesuviana.